![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, August 16, 2024 10:47:32 PM
From a story published today: "The CEO of Telomir Pharmaceuticals, Dr. Christopher Chapman partnered with Dr. Michael Roizen from the Cleveland Clinic to test a new drug aimed at lengthening telomere caps on human stem cells."
The story: https://www.mysuncoast.com/2024/08/16/abc7-exclusive-new-study-reveals-promising-results-age-reversal-pill-dogs/
The reported rejuvenation of two dogs (not laboratory dogs) is impressive.
Telomir is now able to make some or all of the claims about rejuvenation that justifiably excited investors in MYMD.
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM
VOCODIA HOLDINGS INC. (OTCMKTS: VHAI) and TRACCOM INC. (OTCMKTS: TRCC) have signed an MOU to form a Joint Venture that will Revolutionize Event Monitoring with Narrative AI • VHAI • Jan 15, 2025 2:53 PM
UAV Corp (OTC: UMAV) Engages Legal Counsel to Initiate Uplisting Process with Ultimate Goal of NASDAQ Listing • UMAV • Jan 15, 2025 8:30 AM
HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer • HLYK • Jan 15, 2025 8:00 AM
Zefiro Methane Corp. Subsidiary Awarded Slate of Government of Ohio-Funded Environmental Remediation Projects • ZEFI • Jan 15, 2025 7:33 AM